BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Hepatol. Apr 27, 2026; 18(4): 116689
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.116689
Figure 1
Figure 1 Schematic diagram illustrating the role of innate immune immunometabolic reprogramming in non-alcoholic fatty liver disease pathogenesis. PAMPs: Pathogen-associated molecular patterns; LPS: Lipopolysaccharide; mTOR: Mechanistic target of rapamycin.